You just read:

OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5

News provided by

OncoMed Pharmaceuticals, Inc.

Apr 28, 2011, 08:30 ET